Cardinal Health Lifts FY25 EPS Outlook, Sees Growth Despite Tariff Risks Moderna Expands Cost-Cutting Program By Up To $1.7 Billion, FDA Approval For Flu/COVID-19 Combo Shot Delayed Into 2026 ...